Personas / Equipo Humano

Angel Montero Carcaboso

Buscador de publicaciones

Publicaciones

  • Rodriguez-Hernandez CJ, Mateo-Lozano S, Garcia-López M, Casalà C, Briansó F, Castrejon N, Rodriguez E, Suñol M, Carcaboso AM, Lavarino C, Mora J and de Torres C.

    Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens

    Oncotarget . 7(13): 16112-16129. Nº de citas: 17

    [doi:10.18632/oncotarget.7448]

  • Monterrubio C, Pascual-Pastó G, Cano F, Vilà-Ubach M, Manzanares-Quintela A, Schaiquevich P, Tornero JA, Sosnik A, Mora J and Carcaboso AM.

    SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery

    Biomaterials . 79: 69-78. Nº de citas: 42

    [doi:10.1016/j.biomaterials.2015.11.055]

  • Nailor A, Walker, DA, Jacques, TS, Warren, KE, Brem, H, Kearns, PR, Greenwood, J, Penny, JI, Pilkington, GJ, Carcaboso AM, Fleischhack, G, Macarthur, D, Slavc, I, Meijer, L, Gill, S, Lowis, S, van Vuurden, DG, Pearl, MS, Clifford, SC, Morrissy, S, Ivanov, DP, Beccaria, K, Gilbertson, RJ, Straathof, K, Green, JJ, Smith, S, Rahman, R and Kilday, JP.

    Highlights of Children with Cancer UK's Workshop on Drug Delivery in Paediatric Brain Tumours.

    ecancermedicalscience . 10: 630-630. Nº de citas: 2

    [doi:10.3332/ecancer.2016.630]

  • Daryani VM, Patel YT, Tagen M, Turner DC, Carcaboso AM, Atkinson JM, Gajjar A, Gilbertson RJ, Wright KD and Stewart CF.

    Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric Ependymoma.

    CPT: pharmacometrics & systems pharmacology . 5(4): 211-221. Nº de citas: 6

    [doi:10.1002/psp4.12075]

  • Monterrubio C, Paco-Mercader S, Vilà-Ubach M, Rodriguez E, Glisoni R, Lavarino C, Schaiquevich P, Sosnik A, Mora J and Carcaboso AM.

    Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts

    PHARMACEUTICAL RESEARCH . 32(9): 2889-2900. Nº de citas: 10

    [doi:10.1007/s11095-015-1671-9]

  • Ordóñez JL, Amaral AT, Carcaboso AM, Herrero-Martín D, Del Carmen García-Macías M, Sevillano V, Alonso D, Pascual-Pastó G, San-Segundo L, Vilà-Ubach M, Rodrigues T, Fraile S, Teodosio C, Mayo-Iscar A, Aracil M, Galmarini CM, Tirado OM, Mora J and de Álava E.

    The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

    Oncotarget . 6(22): 18875-18890. Nº de citas: 69

    [doi:10.18632/oncotarget.4303]

  • Cockle JV, Picton S, Levesley J, Ilett E, Carcaboso AM, Short S, Steel LP, Melcher A, Lawler SE and Brüning-Richardson A.

    Cell migration in paediatric glioma; characterisation and potential therapeutic targeting

    BRITISH JOURNAL OF CANCER . 112(4): 693-703. Nº de citas: 27

    [doi:10.1038/bjc.2015.16]

  • Schaiquevich P, Carcaboso AM, Buitrago E, Taich P, Opezzo J, Bramuglia G and Chantada GL.

    OCULAR PHARMACOLOGY OF TOPOTECAN AND ITS ACTIVITY IN RETINOBLASTOMA

    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES . 34(9): 1719-1727. Nº de citas: 31

    [doi:10.1097/IAE.0000000000000253]

  • Sosnik A and Carcaboso AM.

    Nanomedicines in the future of pediatric therapy

    ADVANCED DRUG DELIVERY REVIEWS . 73: 140-161. Nº de citas: 47

    [doi:10.1016/j.addr.2014.05.004]

  • Parareda A, Català-Mora J, Carcaboso AM, Sola T, Cruz-Martínez O, Díaz J, Salvador-Hernandez H, de Torres C, Álvarez-Sampons A, Suñol M, Vinent-Genestar J, Guimaraens L, Prat-Bartomeu J and Mora J.

    Intra-arterial chemotherapy for retinoblastoma. Challenges of a prospective study

    ACTA OPHTHALMOLOGICA . 92(3): 209-215. Nº de citas: 27

    [doi:10.1111/aos.12295]